Asparaginase is an antineoplastic enzyme, used in the treatment of acute lymphoblastic leukaemia.
EML status history
First added in 1993 (TRS 850) for Unspecified malignant neoplasms of ill-defined or unspecified sites
Removed in 2015 (TRS 994) for Unspecified malignant neoplasms of ill-defined or unspecified sites
Added in 2015 (TRS 994) for Lymphoid leukaemia, not elsewhere classified
- Powder for injection: 10 000 IU in vial.
- Parenteral > General injections > unspecified: 10000 IU in vial powder for injection